Home / EXPLEOSOL.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does EXPLEOSOL.NS make money? Does EXPLEOSOL.NS have pricing power? What's the Earnings Whisper? Will EXPLEOSOL.NS profit more as the business scales? What is EXPLEOSOL.NS's management track record? Is EXPLEOSOL.NS's current price justified?

Expleo Solutions Limited

₹877 -$82.15 (-8.56%)

NSE · 16 Sep 2026 09:31 UTC

Previous Close

₹862.6

Day Range

₹842₹890

Year Range

₹640₹1175.1

Market Cap

13.59B

AVG Volume

161.4K

Trailing/Forward PE

10.27/9.28

PEG ratio

0.43

Dividend Yield

12.62%

Next Earnings Date

2026-11-14

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

EXPLEOSOL.NS Revenue (INR) · TTM by quarter
Period	Revenue (INR) · TTM
27 Q1	10.94B
26 Q4	10.63B
26 Q3	10.32B
26 Q2	10.56B
26 Q1	10.32B
25 Q4	10.25B
25 Q3	10.24B
25 Q2	10.17B
25 Q1	9.92B
24 Q4	9.65B

Net Income (INR) · TTM

EXPLEOSOL.NS Net Income (INR) · TTM by quarter
Period	Net Income (INR) · TTM
27 Q1	1.32B
26 Q4	1.18B
26 Q3	1B
26 Q2	1.04B
26 Q1	997.66M
25 Q4	1.03B
25 Q3	948.64M
25 Q2	1.09B
25 Q1	941.51M
24 Q4	904.39M

Operating Income (INR) · TTM

EXPLEOSOL.NS Operating Income (INR) · TTM by quarter
Period	Operating Income (INR) · TTM
27 Q1	2.06B
26 Q4	1.9B
26 Q3	1.85B
26 Q2	1.8B
26 Q1	1.76B
25 Q4	1.84B
25 Q3	1.83B
25 Q2	1.85B
25 Q1	1.18B
24 Q4	1.13B

EBITDA (INR) · TTM

EXPLEOSOL.NS EBITDA (INR) · TTM by quarter
Period	EBITDA (INR) · TTM
27 Q1	1.91B
26 Q4	1.85B
26 Q3	1.72B
26 Q2	1.82B
26 Q1	1.78B
25 Q4	1.82B
25 Q3	1.73B
25 Q2	1.82B
25 Q1	1.62B
24 Q4	1.56B

Cash Flows (INR) · TTM

EXPLEOSOL.NS Cash Flows (INR) · TTM by quarter
Period	Cash Flows (INR) · TTM
27 Q1	0
26 Q4	0
26 Q3	0
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	340.36M
25 Q1	545.52M
24 Q4	747.42M

EPS (INR) · TTM

EXPLEOSOL.NS EPS (INR) · TTM by quarter
Period	EPS (INR) · TTM
27 Q1	84.83
26 Q4	75.97
26 Q3	64.63
26 Q2	67.04
26 Q1	64.28
25 Q4	66.52
25 Q3	61.13
25 Q2	70.31
25 Q1	60.67
24 Q4	58.28

Expenses (INR) · TTM

EXPLEOSOL.NS Expenses (INR) · TTM by quarter
Period	Expenses (INR) · TTM
27 Q1	1.63B
26 Q4	1B
26 Q3	979.53M
26 Q2	531.98M
26 Q1	531.98M
25 Q4	1.28B
25 Q3	1.33B
25 Q2	1.24B
25 Q1	1.24B
24 Q4	496.99M

Shares Outstanding · TTM

EXPLEOSOL.NS Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
27 Q1	0
26 Q4	0
26 Q3	0
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0

Dividends (INR)

EXPLEOSOL.NS Dividends (INR) by quarter
Period	Dividends (INR)
Jul 26	110
Feb 25	50
Jul 23	5
Jul 18	20
Nov 17	4
Jul 17	20
Nov 16	4
Jul 16	20
Nov 15	4
Jul 15	20

PE Ratio

EXPLEOSOL.NS PE Ratio by quarter
Period	PE Ratio
Sep 26	11.35
Sep 26	11.71
Sep 26	11.83
Aug 26	11.53
Aug 26	11.83
Aug 26	10.74
Aug 26	11.01
Jul 26	10.57
Jul 26	10.55
Jul 26	10.43
Jul 26	10.67
Jul 26	10.77
Jun 26	12.79
Jun 26	12.54
Jun 26	12.14
Jun 26	13.26
May 26	13.53
May 26	13.95
May 26	13.7
May 26	13.04
Apr 26	12.6
Apr 26	12.44
Apr 26	12.89
Apr 26	11.69
Apr 26	11.15
Mar 26	10.23
Mar 26	10.74
Mar 26	10.9
Mar 26	11.32
Feb 26	11.24
Feb 26	12.37
Feb 26	12.71
Feb 26	13.04
Feb 26	13.37
Jan 26	13.57
Jan 26	14.21
Jan 26	14.29
Jan 26	14.49
Dec 25	15.43
Dec 25	16.01
Dec 25	15.91
Dec 25	16.37
Nov 25	17.31
Nov 25	16.74
Nov 25	16.71
Nov 25	15.25
Oct 25	15.78
Oct 25	15.85
Oct 25	15.68
Oct 25	15.51
Oct 25	15.62
Sep 25	14.6
Sep 25	15.62
Sep 25	14.87
Sep 25	15.33
Aug 25	15.6
Aug 25	15.88
Aug 25	16.75
Aug 25	16.74
Aug 25	17.51
Jul 25	18.36
Jul 25	18.18
Jul 25	18.83
Jul 25	19.67
Jun 25	21.01
Jun 25	20.3
Jun 25	20.35
Jun 25	16.8
May 25	17.3
May 25	16.69
May 25	15.32
May 25	13.5
May 25	13.86
Apr 25	14.24
Apr 25	14.21
Apr 25	13.39
Apr 25	12.91
Mar 25	11.33
Mar 25	12.49
Mar 25	12.01
Mar 25	12.66
Feb 25	12.76
Feb 25	14.29
Feb 25	14.51
Feb 25	16.71
Feb 25	17.11
Jan 25	18.02
Jan 25	18.61
Jan 25	18.51
Jan 25	19.99
Dec 24	23.04
Dec 24	23.93
Dec 24	23.63
Dec 24	22.76
Nov 24	22
Nov 24	22.47
Nov 24	20.15
Nov 24	20.32
Oct 24	20.01
Oct 24	19.18

Free Cash Flow Yield

EXPLEOSOL.NS Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	0%
Sep 26	0%
Sep 26	0%
Aug 26	0%
Aug 26	0%
Aug 26	0%
Aug 26	0%
Jul 26	0%
Jul 26	0%
Jul 26	0%
Jul 26	0%
Jul 26	0%
Jun 26	0%
Jun 26	0%
Jun 26	0%
Jun 26	0%
May 26	0%
May 26	0%
May 26	0%
May 26	0%
Apr 26	0%
Apr 26	0%
Apr 26	0%
Apr 26	0%
Apr 26	0%
Mar 26	0%
Mar 26	0%
Mar 26	0%
Mar 26	0%
Feb 26	0%
Feb 26	0%
Feb 26	0%
Feb 26	0%
Feb 26	0%
Jan 26	0%
Jan 26	0%
Jan 26	0%
Jan 26	0%
Dec 25	0%
Dec 25	0%
Dec 25	0%
Dec 25	0%
Nov 25	0%
Nov 25	0%
Nov 25	0%
Nov 25	0%
Oct 25	0%
Oct 25	0%
Oct 25	0%
Oct 25	0%
Oct 25	0%
Sep 25	0%
Sep 25	0%
Sep 25	0%
Sep 25	0%
Aug 25	0%
Aug 25	0%
Aug 25	0%
Aug 25	0%
Aug 25	0%
Jul 25	0%
Jul 25	0%
Jul 25	0%
Jul 25	0%
Jun 25	0%
Jun 25	0%
Jun 25	0%
Jun 25	0%
May 25	0%
May 25	0%
May 25	0%
May 25	0%
May 25	0%
Apr 25	0%
Apr 25	0%
Apr 25	0%
Apr 25	0%
Mar 25	2.75%
Mar 25	2.5%
Mar 25	2.6%
Mar 25	2.46%
Feb 25	2.44%
Feb 25	2.18%
Feb 25	2.15%
Feb 25	1.87%
Feb 25	1.82%
Jan 25	1.73%
Jan 25	1.68%
Jan 25	1.68%
Jan 25	1.56%
Dec 24	2.52%
Dec 24	2.42%
Dec 24	2.45%
Dec 24	2.55%
Nov 24	2.63%
Nov 24	2.58%
Nov 24	2.88%
Nov 24	2.85%
Oct 24	2.9%
Oct 24	3.02%

Price to Sales

EXPLEOSOL.NS Price to Sales by quarter
Period	Price to Sales
Sep 26	1.26
Sep 26	1.3
Sep 26	1.31
Aug 26	1.28
Aug 26	1.31
Aug 26	1.19
Aug 26	1.22
Jul 26	1.17
Jul 26	1.17
Jul 26	1.16
Jul 26	1.18
Jul 26	1.19
Jun 26	1.24
Jun 26	1.22
Jun 26	1.18
Jun 26	1.29
May 26	1.31
May 26	1.36
May 26	1.33
May 26	1.27
Apr 26	1.22
Apr 26	1.21
Apr 26	1.25
Apr 26	1.14
Apr 26	1.08
Mar 26	1.01
Mar 26	1.06
Mar 26	1.07
Mar 26	1.12
Feb 26	1.11
Feb 26	1.22
Feb 26	1.25
Feb 26	1.28
Feb 26	1.32
Jan 26	1.34
Jan 26	1.4
Jan 26	1.41
Jan 26	1.43
Dec 25	1.49
Dec 25	1.55
Dec 25	1.54
Dec 25	1.58
Nov 25	1.67
Nov 25	1.62
Nov 25	1.62
Nov 25	1.47
Oct 25	1.53
Oct 25	1.53
Oct 25	1.51
Oct 25	1.5
Oct 25	1.51
Sep 25	1.47
Sep 25	1.57
Sep 25	1.5
Sep 25	1.54
Aug 25	1.57
Aug 25	1.6
Aug 25	1.69
Aug 25	1.69
Aug 25	1.76
Jul 25	1.85
Jul 25	1.83
Jul 25	1.9
Jul 25	1.98
Jun 25	1.95
Jun 25	1.88
Jun 25	1.88
Jun 25	1.56
May 25	1.6
May 25	1.55
May 25	1.42
May 25	1.25
May 25	1.28
Apr 25	1.32
Apr 25	1.32
Apr 25	1.24
Apr 25	1.2
Mar 25	1.22
Mar 25	1.34
Mar 25	1.29
Mar 25	1.36
Feb 25	1.37
Feb 25	1.53
Feb 25	1.56
Feb 25	1.79
Feb 25	1.84
Jan 25	1.93
Jan 25	2
Jan 25	1.99
Jan 25	2.14
Dec 24	2.19
Dec 24	2.27
Dec 24	2.24
Dec 24	2.16
Nov 24	2.09
Nov 24	2.13
Nov 24	1.91
Nov 24	1.93
Oct 24	1.9
Oct 24	1.82

EV/EBITDA

EXPLEOSOL.NS EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	5.25
Sep 26	5.47
Sep 26	5.55
Aug 26	5.36
Aug 26	5.55
Aug 26	4.86
Aug 26	5.03
Jul 26	4.75
Jul 26	4.74
Jul 26	4.66
Jul 26	4.81
Jul 26	4.87
Jun 26	7.45
Jun 26	7.31
Jun 26	7.08
Jun 26	7.73
May 26	7.88
May 26	8.13
May 26	7.99
May 26	7.6
Apr 26	7.34
Apr 26	7.25
Apr 26	7.51
Apr 26	6.81
Apr 26	6.5
Mar 26	3.94
Mar 26	4.24
Mar 26	4.33
Mar 26	4.57
Feb 26	4.52
Feb 26	5.17
Feb 26	5.37
Feb 26	5.55
Feb 26	5.74
Jan 26	5.86
Jan 26	6.22
Jan 26	6.26
Jan 26	6.38
Dec 25	8.67
Dec 25	9
Dec 25	8.94
Dec 25	9.2
Nov 25	9.73
Nov 25	9.41
Nov 25	9.39
Nov 25	8.57
Oct 25	8.87
Oct 25	8.91
Oct 25	8.81
Oct 25	8.71
Oct 25	8.78
Sep 25	6.83
Sep 25	7.41
Sep 25	6.98
Sep 25	7.25
Aug 25	7.4
Aug 25	7.56
Aug 25	8.05
Aug 25	8.05
Aug 25	8.48
Jul 25	8.97
Jul 25	8.86
Jul 25	9.24
Jul 25	9.71
Jun 25	11.5
Jun 25	11.11
Jun 25	11.14
Jun 25	9.19
May 25	9.46
May 25	9.13
May 25	8.38
May 25	7.39
May 25	7.58
Apr 25	7.79
Apr 25	7.78
Apr 25	7.32
Apr 25	7.06
Mar 25	5.11
Mar 25	5.81
Mar 25	5.52
Mar 25	5.91
Feb 25	5.97
Feb 25	6.89
Feb 25	7.03
Feb 25	8.34
Feb 25	8.58
Jan 25	9.13
Jan 25	9.49
Jan 25	9.43
Jan 25	10.31
Dec 24	12.14
Dec 24	12.66
Dec 24	12.48
Dec 24	11.97
Nov 24	11.54
Nov 24	11.81
Nov 24	10.46
Nov 24	10.56
Oct 24	10.38
Oct 24	9.9

Price/Operating Cashflow

EXPLEOSOL.NS Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 25	36.31
Mar 25	40.06
Mar 25	38.51
Mar 25	40.6
Feb 25	40.91
Feb 25	45.82
Feb 25	46.53
Feb 25	53.57
Feb 25	54.86
Jan 25	57.76
Jan 25	59.67
Jan 25	59.35
Jan 25	64.08
Dec 24	39.76
Dec 24	41.31
Dec 24	40.78
Dec 24	39.28
Nov 24	37.97
Nov 24	38.79
Nov 24	34.78
Nov 24	35.06
Oct 24	34.54
Oct 24	33.1
Oct 24	36.52
Oct 24	37.03
Oct 24	36.36
Sep 24	27.04
Sep 24	27.26
Sep 24	28.02
Sep 24	27
Aug 24	28.74
Aug 24	27.64
Aug 24	26.41
Aug 24	26.96
Aug 24	27.78
Jul 24	26.58
Jul 24	26.06
Jul 24	27.11
Jul 24	26.65
Jun 24	18.69
Jun 24	19.11
Jun 24	19.09
Jun 24	18.46
May 24	18
May 24	18.57
May 24	19.73
May 24	19.62
May 24	19.84
Apr 24	19.47
Apr 24	19.86
Apr 24	19.38
Apr 24	19.79
Mar 24	19.08
Mar 24	19.82
Mar 24	20
Mar 24	20.84
Mar 24	21.35
Feb 24	21.52
Feb 24	22.19
Feb 24	22.47
Feb 24	22.09
Jan 24	22.29
Jan 24	21.71
Jan 24	22.08
Jan 24	21.94
Dec 23	20.42
Dec 23	21.09
Dec 23	21.54
Dec 23	20.38
Dec 23	21.04
Nov 23	21.24
Nov 23	20.72
Nov 23	20.74
Nov 23	21.42
Oct 23	21.73
Oct 23	22.04
Oct 23	21.81
Oct 23	22.35
Sep 23	22.49
Sep 23	23.81
Sep 23	23.85
Sep 23	24.27
Sep 23	22.69
Aug 23	23.01
Aug 23	23.55
Aug 23	23.29
Aug 23	28.75
Jul 23	26.54
Jul 23	26.55
Jul 23	27.23
Jul 23	25.81
Jun 23	26.58
Jun 23	19.36
Jun 23	19.98
Jun 23	20.6
Jun 23	18.99
May 23	17.81
May 23	18.56
May 23	17.87
May 23	16.79

Price to Book

EXPLEOSOL.NS Price to Book by quarter
Period	Price to Book
Sep 26	1.72
Sep 26	1.78
Sep 26	1.8
Aug 26	1.75
Aug 26	1.8
Aug 26	1.63
Aug 26	1.67
Jul 26	1.61
Jul 26	1.6
Jul 26	1.58
Jul 26	1.62
Jul 26	1.64
Jun 26	1.82
Jun 26	1.79
Jun 26	1.73
Jun 26	1.89
May 26	1.93
May 26	1.99
May 26	1.95
May 26	1.86
Apr 26	1.8
Apr 26	1.77
Apr 26	1.84
Apr 26	1.67
Apr 26	1.59
Mar 26	1.51
Mar 26	1.59
Mar 26	1.61
Mar 26	1.67
Feb 26	1.66
Feb 26	1.83
Feb 26	1.88
Feb 26	1.93
Feb 26	1.98
Jan 26	2.01
Jan 26	2.1
Jan 26	2.11
Jan 26	2.14
Dec 25	2.42
Dec 25	2.51
Dec 25	2.5
Dec 25	2.57
Nov 25	2.72
Nov 25	2.63
Nov 25	2.62
Nov 25	2.39
Oct 25	2.48
Oct 25	2.49
Oct 25	2.46
Oct 25	2.43
Oct 25	2.45
Sep 25	2.37
Sep 25	2.54
Sep 25	2.41
Sep 25	2.49
Aug 25	2.53
Aug 25	2.58
Aug 25	2.72
Aug 25	2.72
Aug 25	2.84
Jul 25	2.98
Jul 25	2.95
Jul 25	3.06
Jul 25	3.19
Jun 25	2.97
Jun 25	2.87
Jun 25	2.88
Jun 25	2.38
May 25	2.45
May 25	2.36
May 25	2.17
May 25	1.91
May 25	1.96
Apr 25	2.01
Apr 25	2.01
Apr 25	1.89
Apr 25	1.83
Mar 25	1.84
Mar 25	2.03
Mar 25	1.95
Mar 25	2.06
Feb 25	2.08
Feb 25	2.33
Feb 25	2.36
Feb 25	2.72
Feb 25	2.78
Jan 25	2.93
Jan 25	3.03
Jan 25	3.01
Jan 25	3.25
Dec 24	3.55
Dec 24	3.69
Dec 24	3.64
Dec 24	3.51
Nov 24	3.39
Nov 24	3.46
Nov 24	3.1
Nov 24	3.13
Oct 24	3.08
Oct 24	2.95

No video analysis for this stock yet. Request one from our team.

AI Analysis

Expleo Solutions Limited

Video analysis: EXPLEOSOL.NS

Similar companies